# Biogen Multiple Sclerosis Pregnancy Exposure Registry

> **NCT01911767** · — · COMPLETED · sponsor: **Biogen** · enrollment: 408 (actual)

## Conditions studied

- Multiple Sclerosis
- Exposure During Pregnancy

## Interventions

- **DRUG:** Dimethyl fumarate
- **DRUG:** Peginterferon beta-1a

## Key facts

- **NCT ID:** NCT01911767
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-30
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-02-10
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911767, "Biogen Multiple Sclerosis Pregnancy Exposure Registry". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01911767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*